News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025
April 10, 2025
·
6 min read
Press Releases
Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
April 10, 2025
·
8 min read
Press Releases
NervGen Provides Quarterly “At-The-Market” Equity Program Update
April 9, 2025
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort
April 9, 2025
·
4 min read
Press Releases
Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
April 9, 2025
·
3 min read
Press Releases
Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia
April 8, 2025
·
7 min read
Press Releases
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies
April 8, 2025
·
4 min read
Press Releases
PlasCred Circular Innovations Inc. Announces Alberta Innovates Funding Grant
April 8, 2025
·
6 min read
Press Releases
Entheon Announces Change of Directors
April 7, 2025
·
1 min read
Press Releases
Ruvidar Demonstrates 7 Year Complete Response
April 7, 2025
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us